-+ 0.00%
-+ 0.00%
-+ 0.00%

RaySearch software enables first patient treatment in conformal FLASH proton therapy trial

PUBT·11/17/2026 08:01:40
Listen to the news
RaySearch software enables first patient treatment in conformal FLASH proton therapy trial
  • RaySearch Laboratories' investigational RayStation software supported the first patient treatment in the C-FLASH-01 conformal FLASH proton therapy trial at Penn Medicine.
  • The IBA-sponsored study will enroll 10 patients requiring repeat radiation treatment for head and neck cancer.
  • Treatments use IBA's ConformalFLASH technology on the ProteusPLUS proton therapy system under an FDA-authorized investigational device exemption.
  • The trial will primarily assess treatment feasibility and acute toxicity, with secondary measures covering delivery accuracy, longer-term safety and patient outcomes.
  • FLASH delivers radiation in a fraction of a second, potentially sparing healthy tissue; clinical benefits have yet to be established.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RaySearch Laboratories AB published the original content used to generate this news brief on November 17, 2026, and is solely responsible for the information contained therein.